Baris Turkbey

2 months ago | mdpi.com | Rulon Mayer |Yuan Yuan |Jayaram Udupa |Baris Turkbey

All articles published by MDPI are made immediately available worldwide under an open access license. No special permission is required to reuse all or part of the article published by MDPI, including figures and tables. For articles published under an open access Creative Common CC BY license, any part of the article may be reused without permission provided that the original article is clearly cited. For more information, please refer to https://www.mdpi.com/openaccess.

Nov 5, 2024 | ejnmmires.springeropen.com | Fahmida Haque |Jorge Carrasquillo |Evrim Turkbey |Esther Mena |Liza Lindenberg |Naris Nilubol | +6 more

In this study, three independent clinical trial populations were used to develop and validate the AI model. Detailed information about the DOTATATE PET/CT scans of all three cohorts is listed in Table 1. The first cohort consists of 38 adult patients undergoing Lu-177-DOTATATE treatment for inoperable, metastatic, and histologically proven Pheochromocytoma/Paraganglioma (NCT03206060), referred to as PPGL cohort for the remainder of the study.

Sep 11, 2024 | nature.com | Baris Turkbey

Artificial intelligence can be leveraged to improve the detection of prostate cancer on magnetic resonance imaging; however, before this technology is implemented in clinical practice, further research is required.